✦ LIBER ✦

Late Recurrence in Melanoma: Clinical Implications of Lost Dormancy

✍ Scribed by Faries, Mark B.; Steen, Shawn; Ye, Xing; Sim, Myung; Morton, Donald L.

Book ID: 122913766
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 367 KB
Volume: 217
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2013.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CLINICAL IMPLICATIONS OF CYTOGENETIC ABN

CLINICAL IMPLICATIONS OF CYTOGENETIC ABNORMALITIES IN MELANOMA

✍ Nelson, Mark A.; Thompson, Floyd H.; Emerson, Julia; Aickin, Mikel; Adair, Laure 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 972 KB

Clinical Manifestations and Molecular Ep

Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management

✍ C. J. Clancy; F. Barchiesi; L. Falconi DiFrancesco; A. J. Morris; D. R. Snydman; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 171 KB

Clinical importance of late recurrence i

Clinical importance of late recurrence in soft-tissue sarcomas

✍ Gibbs, John F.; Lee, R. Jeffrey; Driscoll, Deborah L.; McGrath, Brian E.; Mindel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Background and Objectives: Soft-tissue sarcomas (STS) represent a diverse histologic group of malignancies at risk for local and distant failure. We studied the impact of late (5 or more years) vs. early recurrence (less than 5 years) on subsequent outcome. Methods: Four hundred sixty-eight patients

Clinical risk factors and prognostic sig

Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma

✍ M. Moehrle; A. Kraemer; W. Schippert; C. Garbe; G. Rassner; H. Breuninger 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

Clinical implications of the new biology

Clinical implications of the new biology in the development of melanoma vaccines

✍ Hemmila, Mark R.; Chang, Alfred E. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 3 views

There has been a resurgence in clinical research of vaccine therapies, particularly for the treatment of melanoma. The renewed interest in this field is attributable to an increased understanding regarding the immune response to tumors and the immunobiology of melanoma. Molecular biology techniques

Mutation landscape in melanoma patients

Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations

✍ Heinzerling, L; Baiter, M; Kühnapfel, S; Schuler, G; Keikavoussi, P; Agaimy, A; 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 593 KB